Allergan, the California-based pharmaceutical and medical device company, reported a leap in earnings in the third quarter ended on Sept. 28, prompting it to increase guidance figures for the full year. Consolidated net sales for the group rose by 23.6 percent to $978.7 million for the quarter. Revenues from eye ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.